{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:49:35Z","timestamp":1789386575039,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jaci.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T22:04:22Z","timestamp":1223589862000},"page":"174-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years"],"prefix":"10.1016","volume":"123","author":[{"given":"Malgorzata","family":"Setkowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Mastalerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Podolec-Rubis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","article-title":"Clinical practice. Chronic urticaria and angioedema","volume":"346","author":"Kaplan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2008.09.005_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","article-title":"Chronic urticaria: pathogenesis and treatment","volume":"114","author":"Kaplan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.09.005_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2007.08283.x","article-title":"British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children","volume":"157","author":"Grattan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2008.09.005_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12016-007-0038-3","article-title":"Chronic urticaria: recent advances","volume":"33","author":"Greaves","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2008.09.005_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1398-9995.2005.00962.x","article-title":"EAACI\/GA2LEN\/EDF guideline: management of urticaria","volume":"61","author":"Zuberbier","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2008.09.005_bib6","series-title":"Middelton's allergy, principles and practice","first-page":"1695","article-title":"Sensitivity to aspirin and nonsteroidal antiinfalmmatory drugs","author":"Stevenson","year":"2003"},{"key":"10.1016\/j.jaci.2008.09.005_bib7","first-page":"305","article-title":"Aspirin desensitization in patients with aspirin-induced urticaria and angioedema","volume":"16","author":"Grzelewska-Rzymowska","year":"1988","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaci.2008.09.005_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.0303-6987.2004.0195.x","article-title":"Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria","volume":"31","author":"Zembowicz","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaci.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaci.2003.12.323","article-title":"Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma","volume":"113","author":"Mastalerz","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archderm.139.12.1577","article-title":"Safety of cyclooxygenase II inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to non-steroidal anti-inflammatory drugs","volume":"139","author":"Zembowicz","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2008.09.005_bib11","first-page":"194","article-title":"Clinical characteristics of chronic urticaria with aspirin sensitivity","volume":"25","author":"Ye","year":"2005","journal-title":"Korean J Asthma Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.09.005_bib12","first-page":"110","article-title":"How safe are COX-2 inhibitors in NSAIDs-sensitive subjects with cutaneous reactions?","volume":"15","author":"Sanchez-Borges","year":"2003","journal-title":"ACI Int"},{"key":"10.1016\/j.jaci.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2230.2007.02464.x","article-title":"Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance","volume":"32","author":"Asero","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2008.09.005_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2133.2005.06851.x","article-title":"Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant","volume":"154","author":"Mastalerz","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2222.2004.02197.x","article-title":"The human leucocyte antigen-DRB1\u22171302-DQB1\u22170609-DPB1\u22170201 haplotype may be a strong genetic marker for aspirin-induced urticaria","volume":"35","author":"Kim","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2008.09.005_bib16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2008.09.005_bib17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","article-title":"Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria","volume":"328","author":"Hide","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1172\/JCI118325","article-title":"Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?","volume":"96","author":"Fiebiger","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1081-1206(10)62384-8","article-title":"Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs","volume":"88","author":"Asero","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1164\/ajrccm.152.6.8520733","article-title":"Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance","volume":"152","author":"Szczeklik","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/thx.2007.080903","article-title":"Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity","volume":"63","author":"Mastalerz","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/thx.2003.013573","article-title":"Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma","volume":"59","author":"Bochenek","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2008.09.005_bib23","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMoa012705","article-title":"Mast-cell infiltration of airway smooth muscle in asthma","volume":"346","author":"Brightling","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674908015637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674908015637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:12:00Z","timestamp":1758787920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674908015637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0091674908015637"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2008.09.005","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2008.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}